Phase 1 Atopic Dermatitis Clinical Trials
33 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–20 of 33 trials
Recruiting
Phase 1
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
Atopic DermatitisLupusHyper IgE Syndrome From STAT3 Mutation+2 more
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT07262983
Recruiting
Phase 1
A Phase 1 Study of GS101 Injection
Atopic Dermatitis (AD)
Jiangsu Genscend Biopharmaceutical Co., Ltd294 enrolled1 locationNCT07411755
Recruiting
Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Healthy ParticipantsAtopic Dermatitis
Pfizer119 enrolled3 locationsNCT06564389
Recruiting
Phase 1
Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis
Atopic Dermatitis (AD)
Good Molecules, LLC36 enrolled1 locationNCT07146971
Recruiting
Phase 1
A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants
Atopic Dermatitis
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.90 enrolled2 locationsNCT07488065
Recruiting
Phase 1
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Atopic Dermatitis
National Institute of Allergy and Infectious Diseases (NIAID)86 enrolled8 locationsNCT06504160
Recruiting
Phase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
EczemaAtopic Dermatitis (AD)
Arcutis Biotherapeutics, Inc.125 enrolled1 locationNCT07453602
Recruiting
Phase 1
Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients
Moderate-to-severe Atopic Dermatitis
TRex Bio, Inc.115 enrolled14 locationsNCT06934252
Recruiting
Phase 1
The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis
Atopic Dermatitis (AD)
Daniel Kaplan8 enrolled2 locationsNCT06928246
Recruiting
Phase 1
A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.
Atopic Dermatitis
Chong Kun Dang Pharmaceutical519 enrolled2 locationsNCT07358156
Recruiting
Phase 1
Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis
Atopic Dermatitis (AD)
Jiangsu vcare pharmaceutical technology co., LTD10 enrolled1 locationNCT07329101
Recruiting
Phase 1
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Psoriasis (PsO)Atopic Dermatitis (AD)
LAPIX Therapeutics Inc.48 enrolled3 locationsNCT06982352
Recruiting
Phase 1
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Zai Lab (Shanghai) Co., Ltd.84 enrolled1 locationNCT07235384
Not Yet Recruiting
Phase 1
Placebo controlled study testing safety and tolerability of BEL536 in healthy adults.
Atopic Dermatitis
Belenos Biosciences, Inc.40 enrolled2 locationsACTRN12625001365459
Recruiting
Phase 1
Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis
Atopic Dermatitis (AD)Normal Volunteers
Attovia Therapeutics Inc72 enrolled1 locationNCT07205081
Recruiting
Phase 1
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
Atopic Dermatitis
Bambusa Therapeutics63 enrolled10 locationsNCT07239947
Recruiting
Phase 1
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Atopic Dermatitis
Bambusa Therapeutics198 enrolled7 locationsNCT06808477
Recruiting
Phase 1
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Brexogen Inc.45 enrolled3 locationsNCT06055361
Recruiting
Phase 1
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
Atopic Dermatitis
The First Affiliated Hospital of Soochow University9 enrolled1 locationNCT07015762
Recruiting
Phase 1
A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
Atopic DermatitisRheumatoid Arthritis (RA)Hidradenitis Suppurativa (HS)
Shanghai Qilu Pharmaceutical Research and Development Center LTD102 enrolled1 locationNCT06946641